Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Mohammad I, Saleh"'
Publikováno v:
Pharmaceuticals, Vol 17, Iss 6, p 671 (2024)
Background and Objectives: Dasatinib is one of the tyrosine kinase inhibitors. The main use of these agents is inhibition of cancerous cell proliferation. The therapeutic importance of tyrosine kinase inhibitors raises the necessity of many types of
Externí odkaz:
https://doaj.org/article/46de7a43b6ab4c888bd06636567c047a
Publikováno v:
European journal of drug metabolism and pharmacokinetics. 46(3)
Ibrutinib is an antineoplastic agent that reduces B-cell proliferation by inhibiting Bruton's tyrosine kinase. We describes population pharmacokinetics of ibrutinib in healthy adults, and explores potential patient characteristics associated with ibr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::182c418d0699cab167f76f65da696c6d
https://pubmed.ncbi.nlm.nih.gov/33740218
https://pubmed.ncbi.nlm.nih.gov/33740218
Autor:
Hassouneh, Walaa B.1 (AUTHOR) whassouneh.933@gmail.com, Al-Ghazawi, Mutasim A.1 (AUTHOR) alghazam@ju.edu.jo, Saleh, Mohammad I.1 (AUTHOR), Najib, Naji2 (AUTHOR) n_najib@iprc.com.jo
Publikováno v:
Pharmaceuticals (14248247). Jun2024, Vol. 17 Issue 6, p671. 14p.
Autor:
Alshogran, Osama Y.1 oyalshogran@just.edu.jo, Magarbeh, Leen S.1, Alzoubi, Karem H.1, Saleh, Mohammad I.2, Khabour, Omar F.3
Publikováno v:
Inhalation Toxicology. Nov/Dec2018, Vol. 30 Issue 13/14, p519-526. 8p.
Autor:
Hindi, Nagham N.1, Saleh, Mohammad I.1 moh.saleh@ju.edu.jo
Publikováno v:
Clinical & Experimental Pharmacology & Physiology. Jul2018, Vol. 45 Issue 7, p636-642. 7p. 4 Charts, 3 Graphs.
Publikováno v:
Clinical & Experimental Pharmacology & Physiology. Oct2015, Vol. 42 Issue 10, p1030-1035. 6p. 3 Charts.
Publikováno v:
European Journal of Drug Metabolism & Pharmacokinetics; May2021, Vol. 46 Issue 3, p405-413, 9p
Publikováno v:
Drug Week; 6/13/2024, p2215-2215, 1p
Autor:
Saleh, Mohammad I., Bani Melhim, Suhad
Publikováno v:
Journal of Chemotherapy (Taylor & Francis Ltd); Sep2019, Vol. 31 Issue 5, p274-283, 10p
Publikováno v:
European Journal of Drug Metabolism & Pharmacokinetics; Feb2019, Vol. 44 Issue 1, p31-42, 12p